Search by Drug Name or NDC

    NDC 51672-2143-01 Adapalene 1 mg/g Details

    Adapalene 1 mg/g

    Adapalene is a TOPICAL GEL in the HUMAN OTC DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is ADAPALENE.

    Product Information

    NDC 51672-2143
    Product ID 51672-2143_740cf78a-9728-4245-9ca2-448d2c9a997d
    Associated GPIs
    GCN Sequence Number 026436
    GCN Sequence Number Description adapalene GEL (GRAM) 0.1 % TOPICAL
    HIC3 L9B
    HIC3 Description VITAMIN A DERIVATIVES
    GCN 29300
    HICL Sequence Number 011233
    HICL Sequence Number Description ADAPALENE
    Brand/Generic Generic
    Proprietary Name Adapalene
    Proprietary Name Suffix n/a
    Non-Proprietary Name Adapalene
    Product Type HUMAN OTC DRUG
    Dosage Form GEL
    Route TOPICAL
    Active Ingredient Strength 1
    Active Ingredient Units mg/g
    Substance Name ADAPALENE
    Labeler Name Taro Pharmaceuticals U.S.A., Inc.
    Pharmaceutical Class Retinoid [EPC], Retinoids [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215940
    Listing Certified Through 2023-12-31

    Package

    NDC 51672-2143-01 (51672214301)

    NDC Package Code 51672-2143-1
    Billing NDC 51672214301
    Package 1 TUBE in 1 CARTON (51672-2143-1) / 15 g in 1 TUBE
    Marketing Start Date 2022-01-14
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.50267
    Pricing Unit GM
    Effective Date 2023-12-20
    NDC Description ADAPALENE 0.1% GEL
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL a9ca1f7a-71c3-4814-9366-e7e5760bf32c Details

    Revised: 1/2022